New Year Bumper Sale @ Rs. 1 X
Clobnate-N is an allopathic medicine The correct dosage of Clobnate-N depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Clobnate-N is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Clobnate-N safe for pregnant women?
Clobnate-N can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Clobnate-N right away. Take your doctor's advice before taking it again.
Is the use of Clobnate-N safe during breastfeeding?
Clobnate-N may have very limited harmful effects for breastfeeding women.
What is the effect of Clobnate-N on the Kidneys?
Clobnate-N does not damage the kidneys.
What is the effect of Clobnate-N on the Liver?
There are no any side effects of Clobnate-N on the liver.
What is the effect of Clobnate-N on the Heart?
Clobnate-N is not harmful for the heart.
Clobnate-N should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Clobnate-N unless your doctor advises you to do so -
Is this Clobnate-N habit forming or addictive?
No, there is no any evidence that Clobnate-N is addictive.
Interaction between Food and Clobnate-N
Due to a lack of research, nothing can be said about the consequences of taking Clobnate-N together with food.
Interaction between Alcohol and Clobnate-N
No research has been done on this till date. Therefore, it is not known what the effect of taking Clobnate-N with alcohol will be.
Yes, Clobnate-N is effective against bacteria (pseudomonas). But it is also found that pseudomonas can get resistant to this drug. And in that case Clobnate-N will not produce desired results. If you are experiencing no symptomatic relief after taking this medicine inform your doctor.
No, Clobnate-N does not burn but it has been reported to cause a burning sensation and it is a common side effect of this medicine. However, if you are experiencing a burning sensation after taking this drug, then do not hesitate to inform your doctor.
Clobnate-N is a prescription drug, hence do not take Clobnate-N without consulting doctor. It can be harmful for patients to take this medicine without doctor's advice.
Yes, Clobnate-N has been reported to cause hearing loss or deafness which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying this medicine, then consult your doctor and follow his/her instructions.
Yes, Clobnate-N has been reported to cause diarrhea and it is a common side effect of this medicine. Drink plenty of fluids while you are taking this medicine. If you are experiencing diarrhea after taking this drug, consult your doctor immediately without any further delay.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-139
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 750
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neo-Fradin (neomycin sulfate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370